Diclofenac sodium versus ceftazidime for preventing pancreatitis after endoscopic retrograde cholangiopancreatography: a prospective, randomized, controlled trial.
Hauser, G., Blažević, I., Salkić, N., Poropat, G., Giljača, V., Bulić, Z. i Štimac, D. (2017). Diclofenac sodium versus ceftazidime for preventing pancreatitis after endoscopic retrograde cholangiopancreatography: a prospective, randomized, controlled trial.. Surgical endoscopy, 31., 602-610. doi: 10.1007/s00464-016-5004-9
Hauser, Goran, et al. "Diclofenac sodium versus ceftazidime for preventing pancreatitis after endoscopic retrograde cholangiopancreatography: a prospective, randomized, controlled trial.." Surgical endoscopy, vol. 31, 2017, str. 602-610. https://doi.org/10.1007/s00464-016-5004-9
Hauser, Goran, Ivana Blažević, Nermin Salkić, Goran Poropat, Vanja Giljača, Zlatko Bulić i Davor Štimac. "Diclofenac sodium versus ceftazidime for preventing pancreatitis after endoscopic retrograde cholangiopancreatography: a prospective, randomized, controlled trial.." Surgical endoscopy 31 (2017): 602-610. https://doi.org/10.1007/s00464-016-5004-9
Hauser, G., et al. (2017) 'Diclofenac sodium versus ceftazidime for preventing pancreatitis after endoscopic retrograde cholangiopancreatography: a prospective, randomized, controlled trial.', Surgical endoscopy, 31, str. 602-610. doi: 10.1007/s00464-016-5004-9
Hauser G, Blažević I, Salkić N, Poropat G, Giljača V, Bulić Z, i sur.. Diclofenac sodium versus ceftazidime for preventing pancreatitis after endoscopic retrograde cholangiopancreatography: a prospective, randomized, controlled trial.. Surgical endoscopy [Internet]. 2017. [pristupljeno 21.08.2024.];31:602-610. doi: 10.1007/s00464-016-5004-9
G. Hauser, et al., "Diclofenac sodium versus ceftazidime for preventing pancreatitis after endoscopic retrograde cholangiopancreatography: a prospective, randomized, controlled trial.", Surgical endoscopy, vol. 31, str. 602-610, 2017. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:184:430409. [Citirano: 21.08.2024.]